SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-20-000006
Filing Date
2020-03-09
Accepted
2020-03-06 19:12:51
Documents
4
Period of Report
2020-03-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-krightsofferingclosing0.htm 8-K 30143
2 EXHIBIT 5.1 exhibit-51.htm EX-1 8120
3 EXHIBIT 99.1 exhibit991.htm EX-2 7299
4 exhibit991image1a02.jpg GRAPHIC 5087
  Complete submission text file 0000891293-20-000006.txt   53899
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 20696250
SIC: 2834 Pharmaceutical Preparations